Net profit of Torrent Pharmaceuticals rose 17.36% to Rs 453.00 crore in the quarter ended September 2024 as against Rs 386.00 crore during the previous quarter ended September 2023. Sales rose 7.72% to Rs 2831.00 crore in the quarter ended September 2024 as against Rs 2628.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2831.002628.00 8 OPM %33.1731.39 - PBDT859.00760.00 13 PBT661.00559.00 18 NP453.00386.00 17 Powered by Capital Market - Live News

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live News

Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Director from Vice President of the company with effect from 01 April 2024. Powered by Capital Market - Live News

Net profit of Torrent Pharmaceuticals rose 20.90% to Rs 457.00 crore in the quarter ended June 2024 as against Rs 378.00 crore during the previous quarter ended June 2023. Sales rose 10.48% to Rs 2815.00 crore in the quarter ended June 2024 as against Rs 2548.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2815.002548.00 10 OPM %32.1131.04 - PBDT853.00722.00 18 PBT656.00531.00 24 NP457.00378.00 21 Powered by Capital Market - Live News

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 July 2024.Powered by Capital Market - Live News